Over 30 Start-Up Device Companies Confirmed to Date to Present at Medtech Insight/Windhover...

Over 30 Start-Up Device Companies Confirmed to Date to Present at Medtech Insight/Windhover Information's "Investment In Innovation (In3) East" Conference

"Medical Device Investor Day" Symposium Being Held Immediately
Prior

October 22-24, 2008, Boston, MA
IRVINE, Calif.--(Business Wire)--
Medtech Insight, a division of FDC/Windhover and Reed Elsevier and
a leading provider of business information for the medical device
industry, has announced that more than 30 early- to late-stage
companies are confirmed to date to present at their upcoming
"Investment In Innovation (In3) East" conference, being held October
22-24, 2008 at The Westin Copley Place in Boston, MA. Over 50
companies will present on the In3 East stage in total. It is a
do-not-miss event for those looking to partner, invest and network
with the most promising young medical technology companies on course
to impact the worldwide med device market. In3 East will be preceded
by a first-of-its-kind "Medical Device Investor Day" symposium, which
will feature illuminating presentations by approximately 15 of the
most influential large companies in the device space (8 are confirmed
to date).

The two-day In3 East event - the company's 32nd In3 conference -
will showcase over 50 highly promising start-up med device companies
from around the world presenting to an audience of senior business
development and investment executives from the leading medical
technology and healthcare investment firms worldwide, for purposes of
raising funding or forming strategic partnerships. Presenting
companies to date (with the majority presenting at an In3 event for
the first time) include AugmentRx Medical, Inc., BoneGrafix, Cardiola,
Ltd., CardioMag Imaging, Inc., Ceragenix Pharmaceuticals, CeraPedics,
Inc., Cohera Medical, Inc., Core Essence Orthopaedics LLC, Curative
Biosciences, Inc., Cardio Diagnostics, EndoSphere Inc., EyeMarker
Systems, Inc., Healionics Corporation, LineaGen, Inc.,
MicroTransponder Inc., Minnow Medical, mNemoscience GmbH, MTM
Laboratories, nContact Surgical, Inc., Nerites Corporation,
Neurobionix, Osprey Medical Inc., PEAK Surgical, Inc., Polymedix,
Inc., Sentinel Group LLC, Sherlock-NMD, Spinal Elements, ViOptix Inc.,
Vivostat A/S, and Xylos Corporation, among many others being added to
the program regularly.

The single-track In3 East format will include focused 10-minute
presentations by a senior executive from each presenting company in
one main ballroom, each followed immediately by one-on-one meetings
with interested parties in private breakout rooms. The program will
also feature an informative panel discussion entitled "Stories Behind
How Financing Deals Got Done," with panelists to include David Milne,
Managing Partner, SV Life Science Advisers LP; Kevin Connors, General
Partner, Spray Venture Partners; and Amir Nashat, General Partner,
Polaris Ventures. A presenting company product exhibition and
networking reception will take place on Thursday evening, October 23.
A second interactive panel discussion, "FDA Update: Tips for Smooth
and Successful Interactions with CDRH," will be held on Friday
morning, October 24.

In3 East sponsors include AdvaMed, Averion, Battelle, Business
Wire, Edwards Angell Palmer & Dodge, MDMA, Medmarc and The Hartford,
Medical Capital Advisors, Push-Med, The MedTech Group, Ronald Trahan
Associates, TATRC, and FDC Reports' The Gray Sheet. The In3 East
registration fee is $1495 through August 31st ($200 off the regular
rate), $1695 per attendee after this date, with additional discounts
available when registering multiple attendees. Visit
www.windhover.com/in3east08 for regularly updated event details.

Medical Device Investor Day is taking place October 22, and will
showcase illuminating presentations by approximately 15 of the most
influential large companies in the device space. Top executives from
each of these hand-selected companies will speak candidly on what
interests them most in medical device technologies, therapeutic areas,
products, and geographic markets. They will also inform our audience
about partnering opportunities, how companies can maximize their
visibility in front of large company investors, and what role M&A
plays at their companies. The eight confirmed presenting companies for
Investor Day to date include 3M, B. Braun, Becton Dickinson (BD),
Boston Scientific, Covidien, Ethicon, a Johnson & Johnson Company,
Medtronic, and Stryker, among other industry-leading companies being
added regularly to the program. David Cassak, Managing Partner at
Windhover Information, kicks off this exciting day with an opening
keynote address on the state of larger medical technology company M&A
and deal trends. He will be discussing which investment models for
larger companies are working, how larger companies are sustaining
growth and what the current and future appetite is for M&A. Investor
Day is a must-attend event for those interested in what the leaders of
the med device industry are thinking, doing, and planning in terms of
investment. The registration rate for Medical Device Investor Day only
is $795, or this is discounted to $495 when registering for In3 East
at the same time. Visit www.windhover.com/investorday for more
information.

Medtech Insight and its parent company, FDC/Windhover and Reed
Elsevier, have established a reputation as holding the premier forums
worldwide for discerning senior executives in the medical device,
diagnostics, biotech, and pharmaceutical business development and
investment communities to meet and screen promising early-stage life
sciences companies in need of funding, acquisition and/or strategic
partnership, and to network with key decision makers in the industry.
Over 1400 emerging medical technology company presenters and over 7500
attendees have participated at In3 events over the past 7 years.

Medtech Insight and FDC/Windhover will also hold their "Investment
In Innovation (In3) West" conference at The Palazzo in Las Vegas, NV,
March 2-4, 2009, followed by "Investment In Innovation (In3) Europe"
at the Marriott Rive Gauche Hotel in Paris, April 29-30.

Medtech Insight, a division of FDC/Windhover and
Reed Elsevier
Kristy Grimes, 480-985-9512
or 888-202-5939 toll-free in the U.S.
kristy@medtechinsight.com
Kayleen Kell, 949-453-0071, ext. 313
or 888-290-2225 toll-free in the U.S.
kayleen@medtechinsight.com
www.medtechinsight.com

Copyright Business Wire 2008